TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%
Elixir Medical’s coronary implant, DynamX bioadaptor, has been proven to significantly reduce the risk of device-related cardiac events compared with…
Elixir Medical’s coronary implant, DynamX bioadaptor, has been proven to significantly reduce the risk of device-related cardiac events compared with…
RefleXion Medical’s SCINTIX biology-guided radiotherapy platform (BgRT) has shined in an observational study involving lung and bone cancer patients. During…
Natera’s Signatera assay has been found to accurately predict if a patient with muscle-invasive bladder cancer (MIBC) will benefit from…
Boehringer Ingelheim and Click Therapeutics’ digital therapeutic has met its primary endpoint in a Phase III schizophrenia study. While not…
US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The…
Experts are emphasising that safeguarding patient data from corporations and cyberattacks is vital for the NHS to create a single…
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory…
A £29bn investment into the National Health System (NHS) is ‘substantial’, but reform of the system is essential to ‘fix…
The UK Government has announced a £600m ($764m) funding pot to create a new Health Data Research Service, reducing red…
Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at…